Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Inventory Average: 2020-2025

Historic Inventory Average for Pharming Group N.V (PHAR) over the last 5 years, with Sep 2025 value amounting to $65.4 million.

  • Pharming Group N.V's Inventory Average rose 7.77% to $65.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.4 million, marking a year-over-year increase of 7.77%. This contributed to the annual value of $56.3 million for FY2024, which is 105.23% up from last year.
  • According to the latest figures from Q3 2025, Pharming Group N.V's Inventory Average is $65.4 million, which was up 6.33% from $61.5 million recorded in Q2 2025.
  • Pharming Group N.V's 5-year Inventory Average high stood at $65.4 million for Q3 2025, and its period low was -$3.3 million during Q3 2022.
  • Over the past 3 years, Pharming Group N.V's median Inventory Average value was $57.5 million (recorded in 2025), while the average stood at $48.8 million.
  • Its Inventory Average has fluctuated over the past 5 years, first slumped by 122.43% in 2021, then surged by 5,789.77% in 2023.
  • Pharming Group N.V's Inventory Average (Quarterly) stood at -$1.2 million in 2021, then increased by 20.98% to -$968,747 in 2022, then spiked by 5,789.77% to $55.1 million in 2023, then rose by 7.00% to $59.0 million in 2024, then climbed by 7.77% to $65.4 million in 2025.
  • Its Inventory Average was $65.4 million in Q3 2025, compared to $61.5 million in Q2 2025 and $57.5 million in Q1 2025.